路透2月11日 - WuXi Biologics (Cayman) Inc 2269.HK:
中国药明生物:2025年利润将增长约45.3%
浏览详情,请点击此处
(发稿 刘珞焱)
((Luoyan.Liu@thomsonreuters.com; +86 152 1055 8919;))
路透2月11日 - WuXi Biologics (Cayman) Inc 2269.HK:
中国药明生物:2025年利润将增长约45.3%
浏览详情,请点击此处
(发稿 刘珞焱)
((Luoyan.Liu@thomsonreuters.com; +86 152 1055 8919;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.